Inventor · disambiguated record
Bakary-Barry Toure
Also filed as: TOURE BAKARY-BARRY · TOURÉ BAKARY-BARRY
16 granted patents·7 pending applications·71 citations·filing 2010–2025
92Inventor score
Files withNIDO BIOSCIENCES INC9NOVARTIS AG7CHEN CHRISTINE HIU-TUNG2CAFERRO THOMAS RAYMOND1CHEUNG ATWOOD KIM1
Top patents by PatentIndex Score
23 records- 0194US11667624B2Indole compounds as androgen receptor modulatorsNIDO BIOSCIENCES INC·Filed 2021·Granted Jun 6, 2023·3 cites·19 claims
- 0293US12012398B2Bicyclic compounds as androgen receptor modulatorsNIDO BIOSCIENCES INC·Filed 2022·Granted Jun 18, 2024·2 cites·12 claims
- 0392US10968235B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2019·Granted Apr 6, 2021·3 cites·3 claims
- 0492US10077276B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Sep 18, 2018·15 cites·22 claims
- 0591US9163003B24-piperidinyl compounds for use as tankyrase inhibitorsCHEN CHRISTINE HIU-TUNG·Filed 2012·Granted Oct 20, 2015·13 cites·20 claims
- 0690US12448368B2Indole compounds as androgen receptor modulatorsNIDO BIOSCIENCES INC·Filed 2023·Granted Oct 21, 2025·1 cites·24 claims
- 0790US10336774B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2018·Granted Jul 2, 2019·7 cites·22 claims
- 0886US10287266B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted May 14, 2019·8 cites·13 claims
- 0985US8957068B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2012·Granted Feb 17, 2015·13 cites·28 claims
- 1083US11780845B2FGFR inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Granted Oct 10, 2023·1 cites·2 claims
- 1179US9181266B22-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitorsCHEUNG ATWOOD KIM·Filed 2012·Granted Nov 10, 2015·3 cites·13 claims
- 1278US2025122176A1Indole compounds as androgen receptor modulatorsNIDO BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1377US2022073537A1N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1475US11952386B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Apr 9, 2024·0 cites·12 claims
- 1575US2024368137A1Bicyclic compounds as androgen receptor modulatorsNIDO BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1674US12209098B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·26 claims
- 1774US12168650B2Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrileNIDO BIOSCIENCES INC·Filed 2023·Granted Dec 17, 2024·0 cites·13 claims
- 1868US2025129042A1Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1h-indole-7-carbonitrileNIDO BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1965US8809352B2Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancerMILLER-MOSLIN KAREN·Filed 2010·Granted Aug 19, 2014·2 cites·4 claims
- 2056USRE46942E4-piperidinyl compounds for use as tankyrase inhibitorsNOVARTIS AG·Filed 2012·Granted Jul 10, 2018·0 cites·36 claims
- 2156US2022306609A1Bicyclic compounds as androgen receptor modulatorsNIDO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2250US2025154154A1Src inhibitors and uses thereofRELAY BINNEY STREET 2ND FLOOR·Filed 2021·Application pending·0 cites
- 2342US2025263396A1Crystalline forms of 3-(5-(2-hydroxy-2- methylpropoxy)-6-methypyrazin-2-yl)-1h-indole-7-carbonitrileNIDO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bakary-Barry Toure files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →